You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
紅日藥業(300026.SZ):鹽酸莫西沙星氯化鈉注射液中標第三批國家藥品集採
格隆匯 08-20 17:11

格隆匯 8 月 20日丨紅日藥業(300026.SZ)公佈,2020820日,公司參加了家組織藥品集中採購和使用聯合採購辦公室(“聯採辦”)組織的第三批國家組織藥品集中採購。

已獲得國家藥品監督管理局下發《藥品註冊批件》的公司產品鹽酸莫西沙星氯化鈉注射液(商品名:安若泰)參加了本次集中採購並中標。

第三批國家組織藥品集中帶量採購堅持國家組織、聯盟採購、平台操作的總體思路和工作機制;堅持帶量採購、招採合一、確保使用;堅持高質量標準,主要政策和組織操作模式,並進一步完善相關規則,推薦藥品集中帶量採購制度的常態化,不再選擇部分城市試點,一次招採即在全國同步實施

此次公司產品鹽酸莫西沙星氯化鈉注射液中選進一步提升紅日藥業品牌效應擴充合作渠道,提升合作伙伴能力,增厚公司業績,增強公司其他新上市產品市場競爭力!

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account